No Data
This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
D. Boral Capital Initiates MediciNova(MNOV.US) With Buy Rating, Announces Target Price $9
D. Boral Capital Initiates Coverage On MediciNova With Buy Rating, Announces Price Target of $9
MediciNova Analyst Ratings
MediciNova Highlights Strategic Focus On Non-Dilutive Funding With NIH-Funded ALS Trial And Canadian Long COVID Study, Reports Strong $42.3M Cash Position, And Reaffirms Commitment To Sustainable Growth And Shareholder Transparency
MediciNova Provides Update in Letter to Stockholders